Back to Search Start Over

TPT1/ TCTP-regulated pathways in phenotypic reprogramming

Authors :
Amson, Robert
Pece, Salvatore
Marine, Jean-Christophe
Di Fiore, Pier Paolo
Telerman, Adam
Fiore, Pier Paolo Di
Laboratoire de Biologie et de Pharmacologie Appliquée (LBPA)
École normale supérieure - Cachan (ENS Cachan)-Centre National de la Recherche Scientifique (CNRS)
Università degli Studi di Milano [Milano] (UNIMI)
Centre de Génétique Humaine
Université Catholique de Louvain = Catholic University of Louvain (UCL)
European Institute of Oncology [Milan] (ESMO)
Source :
Trends in Cell Biology, Trends in Cell Biology, Elsevier, 2013, 23 (1), pp.37-46. ⟨10.1016/j.tcb.2012.10.002⟩
Publication Year :
2012

Abstract

International audience; Evolutionary conserved and pleiotropic, the TPT1/TCTP gene (translationally controlled tumor protein, also called HRF, fortilin), encodes a highly structured mRNA shielded by ribonucleoproteins and closely resembling viral particles. This mRNA activates, as do viruses, protein kinase R (PKR). The TPT1/TCTP protein is structurally similar to mRNA-helicases and MSS4. TPT1/TCTP has recently been identified as a prognostic factor in breast cancer and a critical regulator of the tumor suppressor p53 and of the cancer stem cell (SC) compartment. Emerging evidence indicates that TPT1/TCTP is key to phenotypic reprogramming, as shown in the process of tumor reversion and possibly in pluripotency. We provide here an overview of these diverse functions of TPT1/TCTP.

Details

ISSN :
18793088 and 09628924
Volume :
23
Issue :
1
Database :
OpenAIRE
Journal :
Trends in cell biology
Accession number :
edsair.doi.dedup.....e8229c7f33d64b06ea44fad8e8077e8c
Full Text :
https://doi.org/10.1016/j.tcb.2012.10.002⟩